Business
Video abstracts re. Speedboat procedures in India
Video abstracts re. Speedboat procedures in India.
About this update from Creo Medical Group Plc
[{"type":"text","content":"\n \nRNS Number : 5509C Creo Medical Group PLC 11 February 2020 \n\nCreo Medical Group plc\n(\"Creo\" or the \"Company\")\n \nVideo abstracts featuring Speedboat procedures in India\n \nCreo Medical Group plc (AIM: CREO), a medical device company focused on the emerging field of surgical endoscopy, announces that the Company's Speedboat device has featured in two newly published video abstracts published by clinicians from the Asian Institute of Gastroenterology, Hyderabad, India.\n \nBoth video abstracts were authored by experts in the field of Gastrointestinal (\"GI\") therapeutic endoscopy for the Asian Institute of Gastroenterology, Hyderabad, India. These procedures follow on from the first in-human use of the Speedboat device in India as announced in November last year, as well as additional procedures in multiple sites in the US, UK, Spain, South Africa and, more recently, Australia.\n \nThe first video abstract, published on Video GIE, the official video journal of the American Society of Gastrointestinal Endoscopy, is titled, \"Peroral endoscopic myotomy in a patient with failed Heller's myotomy by use of a novel bipolar radiofrequency device.\" The abstract can be viewed on:\nhttps://www.videogie.org/article/S2468-4481(19)30344-3/fulltext\n \nThe second video abstract, published via an open access content publisher, Thieme Group, is titled, \"Endoscopic dissection of an esophageal submucosal tumor using a novel bipolar radiofrequency device\" and can be viewed online here: https://www.thieme-connect.de/products/ejournals/html/10.1055/a-1089-7680\n \nCraig Gulliford, Chief Executive Officer, commented: \"We are delighted to see physicians from different parts of the world not only treating patients but quickly getting published in video form which really highlights the power of advanced energy in the flexible endoscopy setting. Particularly impressive is the size of blood vessels which are being managed with ease using microwave energy and our Speedboat where traditional technology would have struggled even with multiple devices being deployed.\"\n \n \n\n\n\nCreo Medical Group plc\n\n\ninvestors.creomedical.com\n\n\n\n\nRichard Rees (CFO)\n\n\n+44 (0)1291 606 005 \n\n\n\n\n \n\n\n \n\n\n\n\nCenkos Securities\n\n\n+44 (0)20 7397 8900\n\n\n\n\nStephen Keys / Cameron...